share_log

Lake Street Maintains Buy on Better Therapeutics, Lowers Price Target to $5

Benzinga ·  Apr 14, 2023 08:48

Lake Street analyst Thomas Flaten maintains Better Therapeutics (NASDAQ:BTTX) with a Buy and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment